Transplantation最新文献

筛选
英文 中文
Operationalizing Cardiac Xenotransplantation: An Administrative Playbook. 心脏异种移植的操作:管理手册。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-11-10 DOI: 10.1097/TP.0000000000005936
Jeffrey S Wolf, David Marcozzi, Mark Gladwin, Nicole Gatewood, Isabel Siegel, Catherine Miller, Cindy Dove, Nance Conney, Deborah Kotz, Kapil Saharia, Louisa A Peartree, Michelle Harris Williams, Henry Silverman, George Sprinkel, Emily H Wein, Bartley P Griffith, Muhammad M Mohiuddin, Susan Durbin Kinter, Martha O Jurczak, Bert W O'Malley
{"title":"Operationalizing Cardiac Xenotransplantation: An Administrative Playbook.","authors":"Jeffrey S Wolf, David Marcozzi, Mark Gladwin, Nicole Gatewood, Isabel Siegel, Catherine Miller, Cindy Dove, Nance Conney, Deborah Kotz, Kapil Saharia, Louisa A Peartree, Michelle Harris Williams, Henry Silverman, George Sprinkel, Emily H Wein, Bartley P Griffith, Muhammad M Mohiuddin, Susan Durbin Kinter, Martha O Jurczak, Bert W O'Malley","doi":"10.1097/TP.0000000000005936","DOIUrl":"https://doi.org/10.1097/TP.0000000000005936","url":null,"abstract":"<p><strong>Abstract: </strong>As the field of xenotransplantation advances, institutions must navigate a complex landscape of nonclinical challenges to ensure safe and ethical implementation. This article presents a detailed account of the planning and execution of the first 2 human cardiac xenotransplants performed at the University of Maryland School of Medicine and Medical Center. Beyond the surgical innovation, these procedures required extensive coordination across regulatory, ethical, financial, legal, administrative, and operational domains. Drawing from institutional experience-including after-action analyses and interdisciplinary collaboration-we outline key strategies for Food and Drug Administration authorization, staff education, infection control, financial structuring, and communications planning. We also explore ethical considerations in patient selection and consent, emphasizing transparency, autonomy, and public health safeguards. This article serves as a practical guide for institutions preparing to undertake xenotransplantation, offering insights into the infrastructure and foresight necessary to support this transformative but complex medical advance.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Removing the Mandatory Sobriety Period on Waitlist and Posttransplant Outcomes of Patients With and Without Alcohol-associated Liver Disease. 取消强制清醒期对有或无酒精相关性肝病患者等待名单和移植后结果的影响
IF 4.9 2区 医学
Transplantation Pub Date : 2026-11-10 DOI: 10.1097/TP.0000000000005924
Winnie Gaya Shivega, Madelaine A Hack, Carolyn C Chang, Pushpa Neppala, Alexandra Bolognese, C Kristian Enestvedt, Ali Olyaei, Erin Maynard, Willscott E Naugler, David L Scott, Oren Shaked, David C Woodland, Christopher R Connelly
{"title":"Impact of Removing the Mandatory Sobriety Period on Waitlist and Posttransplant Outcomes of Patients With and Without Alcohol-associated Liver Disease.","authors":"Winnie Gaya Shivega, Madelaine A Hack, Carolyn C Chang, Pushpa Neppala, Alexandra Bolognese, C Kristian Enestvedt, Ali Olyaei, Erin Maynard, Willscott E Naugler, David L Scott, Oren Shaked, David C Woodland, Christopher R Connelly","doi":"10.1097/TP.0000000000005924","DOIUrl":"https://doi.org/10.1097/TP.0000000000005924","url":null,"abstract":"<p><strong>Background: </strong>This single-center study assessed the impact of eliminating the mandatory 6-mo sobriety requirement on waitlist and post-liver transplant (LT) outcomes among patients with and without alcohol-associated liver disease (ALD).</p><p><strong>Methods: </strong>Adult patients listed for LT from 2010 to 2023 and followed through 2025 were analyzed. Era 1 (<2018) required ≥6 mo of sobriety, whereas era 2 (≥2018) did not. Competing risk models compared waitlist outcomes across eras. Post-LT survival was compared across eras, followed by a subgroup analysis of era 2 ALD recipients stratified by pre-LT sobriety duration.</p><p><strong>Results: </strong>ALD listings increased (26% versus 42%), whereas non-ALD declined in era 2 (74% versus 58%). In era 2, listed ALD candidates had a higher likelihood of transplant (hazard ratio, 1.90; P < 0.001), lower likelihood of death/deterioration (hazard ratio, 0.48; P = 0.03), and shorter listing-to-LT time (204 versus 98 d; P = 0.004), whereas non-ALD likelihood of transplant, death/deterioration, and time-to-LT were unchanged. One-year post-LT survival was similar across eras, whereas 3- and 5-y survival were higher in era 2 (83% versus 91%; P = 0.01), driven by improved ALD survival with unchanged non-ALD survival. In a subgroup analysis of era 2 ALD transplant recipients, the <6-mo sobriety group had higher transplant Model of End-stage Liver Disease scores (34 versus 28; P < 0.001) lower unadjusted 1-y survival (88% versus 97%; P = 0.04) but similar survival after adjustment for Model of End-stage Liver Disease score (P = 0.29) compared with the 6-mo sobriety group. Recidivism, rejection, and nonadherence rates were similar between groups.</p><p><strong>Conclusions: </strong>Liberalization of sobriety policy improved access to LT and long-term survival for ALD patients without compromising non-ALD outcomes.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mental Health, Disorders and Symptoms in Living Donors: Where are Areas for Improvement? 活体供体的精神健康、疾病和症状:哪里有待改进?
IF 4.9 2区 医学
Transplantation Pub Date : 2026-11-05 DOI: 10.1097/TP.0000000000005966
Andrea F DiMartini, Akhil Shenoy, Roberto Leon-Barriera, Jennifer Steel, Swaytha Ganesh, Deborah Maurer, Mary Amanda Dew
{"title":"Mental Health, Disorders and Symptoms in Living Donors: Where are Areas for Improvement?","authors":"Andrea F DiMartini, Akhil Shenoy, Roberto Leon-Barriera, Jennifer Steel, Swaytha Ganesh, Deborah Maurer, Mary Amanda Dew","doi":"10.1097/TP.0000000000005966","DOIUrl":"10.1097/TP.0000000000005966","url":null,"abstract":"<p><p>The success of living donor transplantation is a testament to the dedicated transplant clinicians and programs who make donor safety and wellbeing their utmost priority. From a psychosocial perspective, additional safeguards are provided by national and international organizations requiring a comprehensive psychosocial assessment by qualified professionals to identify and address any psychosocial issues, including mental health issues, that could complicate post-donation recovery. Overall, in carefully selected donor cohorts, the literature shows donor psychologic wellbeing and mental health, on average, is similar to or exceeds that reported in the general population. However, the literature also reveals clinically relevant higher-risk subgroups, a consistent pattern across liver and kidney donors of risk factors for poorer mental health outcomes: pre-donation characteristics and post-donation events and experiences related to donation. In this overview, we review the literature primarily from the past decade and also additionally use earlier key articles to highlight important mental health outcomes (eg, depression, anxiety). We focus on poorer mental health outcomes with the intent of learning how to improve pre-donation evaluation and post-donation care. We suggest ways to improve donor psychosocial assessments, consider strategies across the donation process that could be used to improve donor follow-up clinical care, and review donation-specific interventions. Closer follow-up of donors' mental health after donation and interventions applied either before or following donation are important areas for future work.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of the Modified Kidney Donor Profile Index on the Nonuse of Kidneys From Donors With Hepatitis C. 修改后的肾脏供者资料指数对丙型肝炎患者不使用肾脏的影响。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-11-05 DOI: 10.1097/TP.0000000000005955
Dema Yaseen Alsabbagh, Massini Merzkani, Mengmeng Ji, Siobhan Sutcliffe, Mei Wang, Muhammad Ulusyar Khan, Abd Asslam Qannus, Krista L Lentine, Gaurav Gupta, Su-Hsin Chang, Tarek Alhamad
{"title":"The Impact of the Modified Kidney Donor Profile Index on the Nonuse of Kidneys From Donors With Hepatitis C.","authors":"Dema Yaseen Alsabbagh, Massini Merzkani, Mengmeng Ji, Siobhan Sutcliffe, Mei Wang, Muhammad Ulusyar Khan, Abd Asslam Qannus, Krista L Lentine, Gaurav Gupta, Su-Hsin Chang, Tarek Alhamad","doi":"10.1097/TP.0000000000005955","DOIUrl":"10.1097/TP.0000000000005955","url":null,"abstract":"<p><strong>Background: </strong>Donor hepatitis C virus (HCV) status was removed from the Kidney Donor Profile Index (KDPI) in October 2024 to better align the score with contemporary outcomes. Little is known about patterns in nonuse and utilization of HCV-exposed kidneys following this revision.</p><p><strong>Methods: </strong>We analyzed Organ Procurement and Transplantation Network data for 145 425 deceased donor kidneys recovered for transplantation between January 2020 and June 2025. Donor HCV status was categorized as nucleic acid test (NAT) + , NAT - /antibody (Ab) + , or NAT - /Ab - . Multivariable logistic regression adjusted for donor characteristics was used to evaluate kidney nonuse. Multinomial logistic regression adjusted for donor and recipient characteristics was used to assess donor HCV status among transplanted kidneys.</p><p><strong>Results: </strong>Through 2024, kidneys from both NAT + and NAT - /Ab + donors had higher adjusted odds of nonuse than NAT - /Ab - kidneys. In early 2025, NAT + kidneys had their lowest observed adjusted odds ratio (aOR) of nonuse during the study period but remained significantly higher than NAT - /Ab - kidneys (aOR, 1.30; 95% confidence interval [CI], 1.01-1.67), whereas NAT - /Ab + kidneys attenuated to nonsignificance (aOR, 1.19; 95% CI, 0.84-1.72). Despite increased candidate willingness to accept both NAT + and NAT - /Ab + kidneys from 2020 to 2025, the odds of transplanting NAT + compared with NAT - /Ab - kidneys did not increase after the KDPI revision (aOR, 0.99; 95% CI, 0.88-1.12). However, transplanting NAT - /Ab + kidneys increased (aOR, 1.27; 95% CI, 1.13-1.43).</p><p><strong>Conclusions: </strong>Removal of HCV from the KDPI equation has improved utilization of NAT - /Ab + kidneys, whereas NAT + kidneys continued to experience excess nonuse despite rising candidate willingness to accept HCV-exposed kidneys.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanotransduction Reshapes Epithelial Fate in Lung Ischemia/Reperfusion Injury Through Piezo1-dependent Calcium Signaling. 机械转导通过piezo1依赖性钙信号重塑肺缺血/再灌注损伤的上皮命运。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-11-05 DOI: 10.1097/TP.0000000000005968
Rongxuan Jiang, Yixing Li, Rongguang Lai, Jingyang Sun, Zhiying Wang, Yihan Lin, Ming Li, Huanhuan Dong, Niuniu Dong, Liren Hou, Haotian Bai, Heng Zhao, Bohao Liu, Jinteng Feng, Yanpeng Zhang, Guangjian Zhang
{"title":"Mechanotransduction Reshapes Epithelial Fate in Lung Ischemia/Reperfusion Injury Through Piezo1-dependent Calcium Signaling.","authors":"Rongxuan Jiang, Yixing Li, Rongguang Lai, Jingyang Sun, Zhiying Wang, Yihan Lin, Ming Li, Huanhuan Dong, Niuniu Dong, Liren Hou, Haotian Bai, Heng Zhao, Bohao Liu, Jinteng Feng, Yanpeng Zhang, Guangjian Zhang","doi":"10.1097/TP.0000000000005968","DOIUrl":"https://doi.org/10.1097/TP.0000000000005968","url":null,"abstract":"<p><strong>Background: </strong>Lung ischemia/reperfusion injury (IRI) remains a major cause of primary graft dysfunction after lung transplantation. Although oxidative stress and inflammation are well-established contributors, the role of biomechanical stress and mechanotransduction in lung IRI has not been fully elucidated.</p><p><strong>Methods: </strong>Public transcriptomic datasets were integrated for differential expression and functional enrichment analyses. Cross-referencing with mechanosensitive ion channel genes identified 5 candidates associated with lung IRI, with Piezo-type mechanosensitive ion channel component 1 (Piezo1) prioritized following independent dataset validation. Rat lung transplantation and in vitro oxygen-glucose deprivation/reoxygenation (OGD/R) models were used to investigate the role of Piezo1 in lung IRI. Piezo1 expression, epithelial injury, calcium accumulation, mitochondrial membrane potential, and apoptosis were evaluated. Genetic knockdown and pharmacological modulation of Piezo1 were performed to determine its functional role.</p><p><strong>Results: </strong>Piezo1 was identified as a mechanosensitive gene associated with lung IRI and was increased following reperfusion. In transplanted lungs, increased Piezo1 expression was accompanied by pulmonary epithelial apoptosis. In human bronchial epithelial cells, OGD/R induced Piezo1 upregulation, intracellular calcium overload, mitochondrial membrane depolarization, and apoptosis. Piezo1 silencing or inhibition alleviated calcium accumulation, preserved mitochondrial membrane potential, reduced apoptotic signaling, and improved cell viability, whereas pharmacological activation of Piezo1 with Yoda1 partially restored the OGD/R-induced injury phenotype in Piezo1-knockdown cells.</p><p><strong>Conclusions: </strong>This study suggests Piezo1 as a potential mechanosensitive regulator of pulmonary epithelial injury during lung IRI, linking biomechanical stress to calcium overload, mitochondrial dysfunction, and apoptosis. Targeting Piezo1-mediated mechanotransduction may represent a potential therapeutic strategy for mitigating graft injury after lung transplantation.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the Letter to the Editor: "Donor and Recipient age in Liver Transplantation: Does Absolute age Matter More Than age Mismatch?" 对致编辑的信的回应:“肝移植中供体和受体的年龄:绝对年龄比年龄不匹配更重要吗?”
IF 4.9 2区 医学
Transplantation Pub Date : 2026-11-03 DOI: 10.1097/TP.0000000000005931
Michele Molinari
{"title":"Response to the Letter to the Editor: \"Donor and Recipient age in Liver Transplantation: Does Absolute age Matter More Than age Mismatch?\"","authors":"Michele Molinari","doi":"10.1097/TP.0000000000005931","DOIUrl":"https://doi.org/10.1097/TP.0000000000005931","url":null,"abstract":"","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum Periostin at 1 y Is Associated With Subsequent Chronic Lung Allograft Dysfunction After Lung Transplantation: A Multicenter Validation Study. 1岁时血清骨膜蛋白与肺移植后慢性同种异体肺移植功能障碍相关:一项多中心验证研究
IF 4.9 2区 医学
Transplantation Pub Date : 2026-11-03 DOI: 10.1097/TP.0000000000005962
Hye Ju Yeo, Jin Ho Jang, Eunjeong Choi, Kipoong Kim, Jin Gu Lee, Song Yee Kim, Samina Park, Kyeongman Jeon, Sung Yoon Lim, Woo Hyun Cho
{"title":"Serum Periostin at 1 y Is Associated With Subsequent Chronic Lung Allograft Dysfunction After Lung Transplantation: A Multicenter Validation Study.","authors":"Hye Ju Yeo, Jin Ho Jang, Eunjeong Choi, Kipoong Kim, Jin Gu Lee, Song Yee Kim, Samina Park, Kyeongman Jeon, Sung Yoon Lim, Woo Hyun Cho","doi":"10.1097/TP.0000000000005962","DOIUrl":"https://doi.org/10.1097/TP.0000000000005962","url":null,"abstract":"<p><strong>Background: </strong>Chronic lung allograft dysfunction (CLAD) remains the leading cause of late morbidity and mortality after lung transplantation, yet clinically useful biomarkers capable of identifying recipients at risk before overt functional decline are lacking. We previously identified serum periostin as a potential biomarker associated with bronchiolitis obliterans syndrome in a single-center cohort.</p><p><strong>Methods: </strong>In this multicenter validation study, we analyzed prospectively biobanked serum samples from the Korean Organ Transplant Registry. Serum periostin, transforming growth factor-beta 1, and interleukin-13 were measured in samples obtained 1 y after lung transplantation. Time-to-event analyses were landmarked at the 1-y biomarker measurement to evaluate associations with subsequent CLAD development. Cox proportional hazards models adjusted for prespecified clinical covariates were used. A periostin cutoff derived from the prior discovery cohort (66.2 ng/mL) was prespecified for validation.</p><p><strong>Results: </strong>Among 202 lung transplant recipients who survived to 1 y, 33 (16.3%) developed CLAD during follow-up. One-year periostin levels were significantly higher in recipients who developed CLAD than in those who remained CLAD-free (84.4 [73.0-114.6] versus 38.2 [26.6-54.3] ng/mL; P < 0.001). In multivariable analyses, higher periostin levels remained associated with increased CLAD risk (adjusted hazard ratio, 1.26 per SD increase; 95% confidence interval, 1.08-1.47; P = 0.003). The prespecified periostin cutoff effectively stratified CLAD-free survival.</p><p><strong>Conclusions: </strong>Serum periostin levels measured 1 y after lung transplantation were associated with subsequent CLAD development. These findings support serum periostin as a clinically informative biomarker for risk stratification among lung transplant recipients who survive the early posttransplant period.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Posttransplant Lymphoproliferative Disorder in Children: A Systematic Review and Meta-analysis. 儿童移植后淋巴增生性疾病的危险因素:系统回顾和荟萃分析。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-11-03 DOI: 10.1097/TP.0000000000005890
Agnese Roveta, Michele Tanturli, Alice Rosati, Annalisa Tondo, Veronica Tintori, Eleonora Gambineri, Francesco Pegoraro
{"title":"Risk Factors for Posttransplant Lymphoproliferative Disorder in Children: A Systematic Review and Meta-analysis.","authors":"Agnese Roveta, Michele Tanturli, Alice Rosati, Annalisa Tondo, Veronica Tintori, Eleonora Gambineri, Francesco Pegoraro","doi":"10.1097/TP.0000000000005890","DOIUrl":"https://doi.org/10.1097/TP.0000000000005890","url":null,"abstract":"<p><strong>Abstract: </strong>Posttransplant lymphoproliferative disorder (PTLD) is the most frequent malignancy in pediatric patients following transplantation. This systematic review aimed to identify risk factors for PTLD in pediatric recipients of solid organ transplantation (SOT) and hematopoietic stem cell transplantation. Following PRISMA guidelines, a literature search was conducted in Medline, Embase, and Cochrane databases for studies published up to August 2025. Study characteristics were extracted, and data on potential risk factors were collected when available. Methodological quality was assessed using the Newcastle-Ottawa Scale for observational studies. Meta-analyses were performed when feasible. Of 4917 records identified, 80 studies were included. Among the investigated variables, negative recipient Epstein-Barr virus (EBV) serology before transplantation emerged as the most significant risk factor for PTLD. The pooled relative risk for PTLD in EBV-seronegative SOT recipients was 3.35 (95% confidence intervals, 2.43-4.60), and this association remained consistent across organ-specific subgroups. Additional variables, such as demographic characteristics, EBV viral load, immunosuppressive therapy, and rejection episodes, showed discordant results across studies, likely reflecting limited data and methodological heterogeneity. Negative pretransplant EBV serology is confirmed as a major risk factor for PTLD in pediatric transplant recipients. Moreover, the findings of this review provide a comprehensive synthesis of the available evidence regarding risk factors of PTLD in pediatric recipients of both SOT and hematopoietic stem cell transplantation, highlighting the need for further large-scale studies to clarify additional determinants.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Significance of Early Donor-derived Cell-free DNA Trajectories After Kidney Transplantation. 肾移植术后早期供体来源的无细胞DNA轨迹的预后意义。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-11-02 DOI: 10.1097/TP.0000000000005959
Kalathil Sureshkumar, Jeffrey A Klein, Dhiren Kumar, Nadiesda Costa, Renata Glehn-Ponsirenas, Peale Chuang, Ling Shen, James Lu, David Wojciechowski, Pranjal Jain, Yihung Huang, Alexander Wiseman, Edmund Huang, Stuart Knechtle, Suphamai Bunnapradist, Rafael Villicana, Puneet Sood, Anil Paramesh, Rashikh A Choudhury, James Piper, Jiashu Xue, Yasir Qazi, Divya Jain, Sandesh Parajuli, Nicolae Leca, Didier A Mandelbrot, Jonathan Bromberg, Thin Thin Maw, Daniel C Brennan, Tarek Alhamad
{"title":"Prognostic Significance of Early Donor-derived Cell-free DNA Trajectories After Kidney Transplantation.","authors":"Kalathil Sureshkumar, Jeffrey A Klein, Dhiren Kumar, Nadiesda Costa, Renata Glehn-Ponsirenas, Peale Chuang, Ling Shen, James Lu, David Wojciechowski, Pranjal Jain, Yihung Huang, Alexander Wiseman, Edmund Huang, Stuart Knechtle, Suphamai Bunnapradist, Rafael Villicana, Puneet Sood, Anil Paramesh, Rashikh A Choudhury, James Piper, Jiashu Xue, Yasir Qazi, Divya Jain, Sandesh Parajuli, Nicolae Leca, Didier A Mandelbrot, Jonathan Bromberg, Thin Thin Maw, Daniel C Brennan, Tarek Alhamad","doi":"10.1097/TP.0000000000005959","DOIUrl":"https://doi.org/10.1097/TP.0000000000005959","url":null,"abstract":"<p><strong>Background: </strong>Early post-transplant elevations in donor-derived cell-free DNA are often attributed to ischemia-reperfusion injury, with uncertain prognostic significance. We assessed whether donor-derived cell-free DNA (dd-cfDNA) results during the first 4 mo post-transplantation are associated with long-term graft outcomes.</p><p><strong>Methods: </strong>We analyzed 1137 kidney transplant recipients enrolled in the prospective multicenter Kidney Outcomes AlloSure Registry. Recipients were categorized into 4 trajectory groups based on dd-cfDNA measurements obtained within the first 4 mo post-transplant: consistently low, transient-elevation, late-elevation, and persistent-elevation. Associations with donor-specific antibody (DSA) development, rejection, graft dysfunction, and graft loss were evaluated over 3 y using hazard regression, with multivariable models adjusted for calculated Panel Reactive Antibody (cPRA) and retransplant.</p><p><strong>Results: </strong>Among the 1137 recipients, 83.7% exhibited consistently low dd-cfDNA, 9.8% transient-elevation, 3.2% late-elevation, and 3.3% persistent-elevation. Late elevation was associated with the highest cumulative incidence of DSA development, whereas persistent-elevation had the highest incidence of rejection, graft dysfunction, and graft loss. Graft loss occurred in 20.0% of recipients with persistent-elevation and 8.8% with late-elevation and was uncommon among consistently low (2.2%) and transient (2.9%) groups. On multivariable analysis, late elevation was independently associated with DSA development, rejection, and graft loss, and persistent-elevation with rejection, graft dysfunction, and graft loss, regardless of prior transplantation or sensitization status.</p><p><strong>Conclusions: </strong>Early dd-cfDNA trajectories stratify kidney transplant recipients into clinically meaningful risk phenotypes. Persistent or late-emerging elevation identifies patients at independently increased risk of rejection and graft loss, with persistent-elevation also associated with graft dysfunction, supporting serial dd-cfDNA monitoring as a tool for early post-transplant risk stratification.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence and Risk Factors for Early Major Neurologic Complications in Lung Transplantation: From Restrictive Cardiopulmonary Bypass to ECMO by Criteria. 肺移植早期主要神经系统并发症的发生率和危险因素:从限制性体外循环到ECMO的标准。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-11-02 DOI: 10.1097/TP.0000000000005961
Vincent Duchesne, Alex Moore, Etienne Revelly, Charles Overbeek, Cédrick Zaouter, Mathilde Fortin, Basil S Nasir, Pasquale Ferraro, Moishe Liberman, Stephan Williams
{"title":"Incidence and Risk Factors for Early Major Neurologic Complications in Lung Transplantation: From Restrictive Cardiopulmonary Bypass to ECMO by Criteria.","authors":"Vincent Duchesne, Alex Moore, Etienne Revelly, Charles Overbeek, Cédrick Zaouter, Mathilde Fortin, Basil S Nasir, Pasquale Ferraro, Moishe Liberman, Stephan Williams","doi":"10.1097/TP.0000000000005961","DOIUrl":"https://doi.org/10.1097/TP.0000000000005961","url":null,"abstract":"<p><strong>Background: </strong>Intraoperative hemodynamic instability and hypoxemia may contribute to early major neurologic complications (EMNC) following lung transplantation. Mechanical circulatory support can mitigate cerebral hypoperfusion, but cardiopulmonary bypass (CPB) is an independent risk factor for EMNC. This study examines the incidence of EMNC transitioning from a restrictive CPB strategy to criteria-based use of extracorporeal membrane oxygenation (ECMO-BC).</p><p><strong>Methods: </strong>We conducted a single-center retrospective cohort study on 389 lung transplant recipients comparing patients managed with restrictive CPB (PRE-ECMO, 2012-2017, n = 288) to those managed with criteria-based ECMO (ECMO-BC, 2022-2024, n = 101). The incidence of EMNC was compared between groups.</p><p><strong>Results: </strong>EMNC occurred in 29 of 280 patients in the PRE-ECMO group and in 5 of 101 patients in the ECMO-BC group (10% versus 5%; P = 0.152), with 78 versus 8 total events, corresponding to an incidence rate ratio of 3.5 (95% confidence interval [CI], 1.7-7.4, P < 0.001). Ischemic stroke was significantly less frequent in the ECMO-BC group (2% versus 9%; P = 0.022). Intraoperative mechanical circulatory support was used in 20% of PRE-ECMO and 43% of ECMO-BC cases (P < 0.001). Patients in the ECMO-BC group were older, had more cardiopulmonary comorbidities, greater intraoperative blood loss (2489 versus 1861 cc; P < 0.001), and more severe primary graft dysfunction at 24 and 72 h (P < 0.001).</p><p><strong>Conclusions: </strong>Transition to ECMO-BC was associated with lower EMNC events and fewer ischemic strokes, but increased intraoperative blood loss and worse early graft function, generating hypotheses for prospective studies that define optimal ECMO indications in lung transplantation.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书